Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model is a research paper published in Molecular Therapy — Methods & Clinical Development (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F30 HL145955
National Institutes of Health
Grant: P50 AR065139
National Institutes of Health
Grant: P50 AR070604
National Institutes of Health
Grant: R01 AG060542
National Institutes of Health
Grant: R01 NS124681
National Institutes of Health
Grant: T32 HL134616
NIAMS NIH HHS
Grant: R01 AR040864
NHLBI NIH HHS
Grant: R01 HL136951
NHLBI NIH HHS
Grant: R01 HL154001
National Institutes of Health
Grant: 5T32HL134616-04
Training To Provide the Knowledge, Skills, and Culture To the Next Generation of Cardiovascular Scientists
National Institutes of Health
Grant: 5R01NS124681-03
Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy
National Institutes of Health
Grant: 5F30HL145955-03
The role of N-6-adenosine and its writer, METTL3, in the cardiac hypertrophic response
National Institutes of Health
Grant: 5R01AG060542-02
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.
National Institutes of Health
Grant: 2P50AR065139-05
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)
National Institutes of Health
Grant: 1P50AR070604-01
Center of Research Translation in Muscular Dystrophy Therapeutic Development
FWCI
1.66
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals